Journal Article10.1086/344658
Antifungal Drug Resistance
TL;DR: The frequency, interpretation, and, in particular, mechanism of resistance to current classes of antifungal agents, particularly the azoles (where resistance has climbed most prominently) are discussed in this review.
read more
Abstract: The increasing incidence of invasive fungal infections is the result of many factors, including an increasing number of patients with severe immunosuppression. Although new drugs have been introduced to combat this problem, the development of resistance to antifungal drugs has become increasingly apparent, especially in patients who require long-term treatment or who are receiving antifungal prophylaxis, and there is growing awareness of shifts of flora to more-resistant species. The frequency, interpretation, and, in particular, mechanism of resistance to current classes of antifungal agents, particularly the azoles (where resistance has climbed most prominently) are discussed in this review.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Echinocandin antifungal drugs
TL;DR: Results of studies of caspofungin in candidaemia and invasive candidiasis suggest equivalent efficacy to amphotericin B, with substantially fewer toxic effects, suggests that combination antifungal therapy could become a general feature of the echinocandins.
1.1K
Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis—State of the Art: Cystic Fibrosis Foundation Consensus Conference
David A. Stevens,Richard B. Moss,Viswanath P. Kurup,Alan P. Knutsen,Paul A. Greenberger,Marc A. Judson,David W. Denning,Reto Crameri,Alan S. Brody,Michael J. Light,Marianne Skov,William Maish,Gianni Mastella +12 more
TL;DR: Virulence factors in Aspergillus that could aggravate these diseases, and particularly immunogenetic factors that could predispose persons to ABPA, were identified and diagnostic criteria that could provide a framework for monitoring were adopted.
Multidrug Resistance: An Emerging Crisis
TL;DR: Considering the significance of MDR, this paper emphasizes the problems associated with MDR and the need to understand its significance and mechanisms to combat microbial infections.
Efflux-Mediated Antifungal Drug Resistance
Richard D. Cannon,Erwin Lamping,Ann R. Holmes,Kyoko Niimi,Philippe Baret,Mikhail V. Keniya,Koichi Tanabe,Masakazu Niimi,André Goffeau,Brian C. Monk +9 more
TL;DR: Phylogenetic analysis of the ABC pleiotropic drug resistance family has provided a new view of the evolution of this important class of efflux pumps, and potential therapeutic approaches that could overcome azole resistance are proposed.
How microorganisms use hydrophobicity and what does this mean for human needs
Anna Krasowska,Karel Sigler +1 more
TL;DR: The future of research seems to lie in finding a way to managing the microbial adhesion process, perhaps by steering cell hydrophobicity.
References
Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections
John H. Rex,Michael A. Pfaller,John N. Galgiani,Marilyn S. Bartlett,Ana Espinel-Ingroff,Mahmoud A. Ghannoum,M Lancaster,Frank C. Odds,Michael G. Rinaldi,Thomas J. Walsh,A L Barry +10 more
TL;DR: The conceptual framework underlying interpretation of antimicrobial susceptibility testing results is examined and these ideas are used to drive analysis of data packages developed by the respective manufacturers that correlate fluconazole and itraconazole MICs with outcome of candidal infections.
855
Efficacy and Safety of Fluconazole Prophylaxis for Fungal Infections after Marrow Transplantation—A Prospective, Randomized, Double-Blind Study
Monica A. Slavin,Barbara A. Osborne,Roger Adams,M J Levenstein,H G Schoch,A R Feldman,Joel D. Meyers,Raleigh A. Bowden +7 more
TL;DR: Prophylactic fluconazole was safe and significantly reduced systemic fungal infections with other benefits, including improved survival at day 110 after marrow transplantation.
833
Candida colonization and subsequent infections in critically ill surgical patients.
TL;DR: The intensity of Candida colonization assessed by systematic screening helps predicting subsequent infections with identical strains in critically ill patients, and offers opportunity for intervention strategies.
815
Reference method for broth dilution antifungal susceptibility testing of yeasts, Approved standard-second edition
Pa Wayne
- 01 Jan 2002
TL;DR: A method for testing the susceptibility of antifungal agents to yeast that cause invasive fungal infections, including Candida species (and Candida glabrata), and Cryptococcus neoformans is described.
656
Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene.
TL;DR: Data demonstrate that CDR2 plays an important role in mediating the resistance of C. albicans to azole antifungal agents.